Exceptionally accomplished software developers sought to build and support compilers for a massively parallel special-purpose supercomputer. Successful hires will join a New York–based interdisciplinary research group pursuing an ambitious, long-term project aimed at achieving major scientific advances in the field of biochemistry and fundamentally transforming the process of drug discovery.
Candidates should have a demonstrated track record of academic, industrial, and/or open-source accomplishments. Relevant areas of expertise might include modifying or porting compilers such as GCC or LLVM, high-level and machine-specific optimizations, code generation, register allocation, instruction scheduling, and C/C++ programming, but specific knowledge of any of these areas is less critical than exceptional intellectual ability and a record of innovation and achievement. We are prepared to reward exceptionally well-qualified individuals with above-market compensation.
Among the group’s current research activities is the development of new algorithms and software for molecular dynamics simulations and data analysis both on commodity clusters and on Anton, a massively parallel special-purpose supercomputer of our group’s design. Successful candidates will have the opportunity to work closely with a number of the world’s leading computational chemists and biologists, and to make fundamental contributions within the fields of biology, chemistry, and medicine.
To submit an application, please use the link provided below:
D. E. Shaw Research does not discriminate in employment matters on the basis of race, color, religion, gender, pregnancy, national origin, age, military service eligibility, veteran status, sexual orientation, marital status, disability, or any other protected class.
About D. E. Shaw Research
D. E. Shaw Research ("DESRES") is an independent research laboratory that conducts basic scientific research in the field of computational biochemistry under the direct scientific leadership of Dr. David Shaw, who serves as its Chief Scientist.